← Every company
Jazz Pharmaceuticals PLC Lobbying
What Jazz Pharmaceuticals PLC discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
JAZZ on carbonthat →Disclosed spend
$1.7M
across every filing on file
Filings
16
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesMedicare/MedicaidTrade (domestic/foreign)Medical/Disease Research/Clinical LabsBudget/AppropriationsPharmacy
16 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | JAZZ PHARMACEUTICALS, INC.Pharmacy | $490K |
| 20261st Quarter (Jan 1 - Mar 31) | JAZZ PHARMACEUTICALS, INC.Pharmacy | $470K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | TARPLIN, DOWNS & YOUNG, LLCHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth Issues | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK HEALTH STRATEGIES, INC. | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | THE NICKLES GROUP, LLCMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK HEALTH STRATEGIES, INC. | $50K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK GROUPHealth IssuesMedical/Disease Research/Clinical Labs | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | THE NICKLES GROUP, LLCMedicare/MedicaidTrade (domestic/foreign) | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPHealth IssuesMedical/Disease Research/Clinical Labs | $50K |
| 20262nd Quarter (Apr 1 - June 30) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCHealth IssuesTrade (domestic/foreign) | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCHealth IssuesTrade (domestic/foreign) | $40K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCMedicare/Medicaid | $30K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on JAZZ
Company overviewEverything on JAZZ in one place, with the price.SEC filingsWhat JAZZ's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat JAZZ's own officers and directors buy and sell.Planned salesSales JAZZ insiders have filed notice of.Executive payWhat JAZZ awarded its chief executive, and what it became.Who lobbies for itThe lobbyists on JAZZ's account, and who they worked for.Federal contractsWhat federal agencies pay JAZZ.PatentsWhat JAZZ is filing at the patent office.